Carfilzomib
| CAS No. | 868540-17-4 |
|---|---|
| MDL No. | MFCD11040997 |
| MF | C40H57N5O7 |
| MW | 719.90 |
| InChI Key | BLMPQMFVWMYDKT-NZTKNTHTSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Carfilzomib is a synthetic tetrapeptide composed of morpholin-4-acetyl, L-2-amino-4-phenylbutanoyl, L-leucyl, and L-phenylalanyl residues, linked sequentially with the C-terminus connected to the amino group of (2S)-2-amino-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-1-one via an amide bond. It is used in the treatment of multiple myeloma, functions as an antineoplastic agent and proteasome inhibitor, and belongs to the class of tetrapeptides, morpholines, and epoxides.
| CAS No. | 868540-17-4 |
|---|---|
| Product Name | Carfilzomib |
Biological Targets
PSMD1·PSMB2·PSMB1·PSMB5·PSMB8·
Associated Conditions
Waldenstrom macroglobulinemia·neoplasm·cancer·neuroendocrine carcinoma·Sezary's disease·
* The information provided here is compiled from public sources and is for reference only.
